Vertex Pharmaceuticals Inc
NASDAQ:VRTX

  • LAST PRICE
    445.2100
  • TODAY'S CHANGE (%)
    4.5700 (1.0371%)
  • Bid / Lots
    435.1000/ 1
  • Ask / Lots
    454.7600/ 1
  • Open / Previous Close
    442.0000 / 440.6400
  • Day Range
    440.3450
    446.1000
  • 52 Week Range
    320.0100
    448.4000
  • Volume
    1,382,490

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 15, 2024

      Show headlines and story abstract

    • 10:30AM ET on Wednesday May 15, 2024 by Dow Jones
      Companies Mentioned: VRTX
      BOSTON--(BUSINESS WIRE)--May 15, 2024--
      Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Americans living in rural America. Prior to founding Homeward in 2022, Dr. Schneider served as President and Chief Medical Officer of Livongo Health, a biotechnology company serving people with chronic conditions including diabetes, hypertension, obesity and behavioral health issues. While there, she led the company through the largest consumer digital health Initial Public Offering in history and the industry's largest merger between Livongo and Teladoc Health. She also served as Chief Medical Officer of Castlight Health, a health care navigation company for self-insured companies.

    • 10:30AM ET on Wednesday May 15, 2024 by Business Wire
      Companies Mentioned: VRTX

      Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Americans living in rural America. Prior to founding Homeward in 2022, Dr. Schneider served as President and Chief Medical Officer of Livongo Health, a biotechnology company serving people with chronic conditions including diabetes, hypertension, obesity and behavioral health issues. While there, she led the company through the largest consumer digital health Initial Public Offering in history and the industry's largest merger between Livongo and Teladoc Health. She also served as Chief Medical Officer of Castlight Health, a health care navigation company for self-insured companies.

  • May 14, 2024

  • May 10, 2024

  • May 9, 2024

Peers Headlines